The uncertain times brought on by the COVID-19 pandemic have affected businesses worldwide, and several sectors of medtech industry are projecting hits to their bottom lines. A number of companies have announced decisions to withdraw financial guidance, cut hours and/or staff, among other major business decisions. Initial impacts of the global pandemic on Wall Street […]
Livongo beats The Street in Q4 results
Livongo Health (NSDQ:LVGO) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Mountain View, Calif.-based company reported losses of -$6 million, or -6¢ per share, on sales of $50.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 137.5% compared with Q4 2018. Adjusted to […]
Livongo inks deal with BCBS Kansas City
Livongo Health (NSDQ:LVGO) said yesterday that it expanded its partnership with Blue Cross & Blue Shield of Kansas City to offer its diabetes program to all of Blue KC’s fully insured clients. The agreement intends to make Livongo available to eligible administrative services only clients with Blue KC as well, according to a news release. Blue […]
Livongo jumps on federal employee benefits deal
Livongo Health (NSDQ:LVGO) shares jumped yesterday after the company landed a two-year deal with the Federal Employees Health Benefits Program that could add as much as $30 million a year to its top line. Mountain View, Calif.-based Livongo developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. Yesterday the […]
Livongo shares gain as first earnings print tops expectations
Livongo (NSDQ:LVGO) shares gained in pre-market trading today after the digital health company posted second-quarter results that beat the consensus forecast on Wall Street, in its first earnings print since its public flotation in July. Mountain View, Calif.-based Livongo said losses widened 129.3% to -$14.3 million, or 76¢ per share, on sales growth of 155.8% […]
Livongo share prices double after upsized $356m IPO
Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing. The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 […]
Livongo boosts IPO to $268m midpoint
Livongo Health yesterday boosted the range on its pending initial public offering, saying the flotation would now fetch nearly $268 million at the midpoint. The Mountain View, Calif.-based company developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. After a series of upsizing announcements, Livongo yesterday said it plans […]
Livongo Health files for $100m IPO
Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose reading […]
Livongo preps for $1B IPO
Livongo Health is preparing for a $1 billion initial public offering this year, according to a new report from The Wall Street Journal. The IPO for the Mountain View, Calif.-based diabetes-focused digital health company is set to drop in the third quarter of this year, according to the report. Read the whole story on our […]
Insulet taps former Medtronic finance exec McMillan as CFO | Personnel Moves – January 8, 2019
Insulet (NSDQ:PODD) said yesterday that it tapped former Medtronic minimally invasive therapies CFO and finance VP Wayde McMillan as its new chief financial officer, replacing Michael Levitz. The Acton, Mass.-based diabetes-focused medtech company said that McMillan will join the company in February and that Levitz will continue as an advisor for a period following the […]
FDA names Flatiron Health’s Abernethy as deputy commish | Personnel Moves, December 19, 2018
The FDA this week named Amy Abernethy, the chief medical officer for Roche subsidiary Flatiron Health, as principal deputy commissioner to replace Rachel Sherman, who is retiring in January. “She’s a highly regarded thought leader who has held numerous positions of leadership in her fields of interest and distinguished herself for her intellect, her passion […]
